Zhiqiang Chen
Nankai University(CN)Fudan University(CN)Chinese PLA General Hospital(CN)People's Liberation Army 401 Hospital(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Cancer, Lipids, and Metabolism, Ferroptosis and cancer prognosis
Most-Cited Works
- → Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis(2022)118 cited
- → TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage(2019)86 cited
- → The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis(2022)51 cited
- → Mannose‐mediated inhibitory effects of PA‐MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF‐κB pathway(2014)48 cited
- → TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection(2015)46 cited
- → Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis(2021)